Search results for "Metas"

showing 10 items of 1693 documents

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

2019

AbstractThe article gives an overview of current treatment options for metastatic hormone receptor-positive and HER2-negative breast cancer. The focus is on combined therapies, e.g., with CDK4/6 inhibition compared with purely endocrine-based therapies in the pre- and postmenopause, presenting the latest study results. The addition of a CDK4/6 inhibitor to endocrine-based therapy with an aromatase inhibitor or fulvestrant leads to a marked improvement in progression-free survival and is independently beneficial whether palbociclib, ribociclib or abemaciclib is involved. The particular clinical status of inhibition of cyclin-dependent kinases argues for its use in the first-line treatment of…

CDK4/6-InhibitorOncologymedicine.medical_specialtymedicine.drug_classMetastasierungPalbociclibCDK4/6 inhibitorHER2-negativMetastasisMammakarzinom03 medical and health scienceschemistry.chemical_compoundbreast cancer0302 clinical medicineBreast cancerInternal medicineMaternity and MidwiferyReview/ÜbersichtmetastasisEndocrine systemMedicineGebFra ScienceAbemaciclib030219 obstetrics & reproductive medicineAromatase inhibitorFulvestrantbusiness.industryhormonrezeptorpositivObstetrics and Gynecologymedicine.diseasechemistryHormone receptorhormone receptor-positivebusinessHER2-negativemedicine.drugGeburtshilfe und Frauenheilkunde
researchProduct

Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI)

2019

Introduction: FRI is a validated computational fluid dynamics (CFD)-based technique using aerosol delivery performance profile, patients’ high-resolution lung CT scans and patient-derived inhalation profiles to simulate aerosol lung deposition. Aims and Objectives: To evaluate lung deposition patterns of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium [BDP/FF/G; TRIMBOW®] pressurized metered dose inhaler (pMDI) and non-extrafine fluticasone furoate/vilanterol/umeclidinium [FluF/VI/UMEC; TRELEGY® ELLIPTA®] dry powder inhaler (DPI) in patients with stable COPD and moderate to very severe airflow obstruction. Methods: Intrathoracic depositions of the inhaled corticoster…

COPDmedicine.medical_specialtyInhalationbusiness.industryInhalerUrologyBeclometasone dipropionaterespiratory systemmedicine.diseaseMetered-dose inhalerFluticasone propionateDry-powder inhalerchemistry.chemical_compoundchemistryMedicineVilanterolbusinessmedicine.drugImaging
researchProduct

Anti-Metastatic Activities of Heparins

2009

Heparins are commonly administered to cancer patients for the treatment and prophylaxis of thromboembolic events. Importantly, apart from the anti-thrombotic action of these drugs, several clinical trials have demonstrated an improved survival of cancer patients who were administered low-molecular-weight heparins (LMWHs). This improved survival was independent of the anti-thrombotic efficacy, since vitamin K antagonists did not improve clinical prognosis. Moreover, this protective effect was not the result of an inhibition of the growth of primary tumors, but rather the prevention of the spreading of cancer through metastases. This has been also shown in some animal experiments. The protect…

CXCR4metastasisheparinCXCL12selectinheparanaseJournal of Cancer Molecules
researchProduct

Non-pegylated liposomal doxorubicin plus cyclophosphamide as first-line therapy in elderly women with HER2 negative metastatic breast cancer.

2022

Background. The use of anthracyclines in metastatic breast cancer (MBC) is limited by cumulative dose-dependent cardiotoxicity mostly in elderly women with comorbidities. The aim of this observational retrospective study was to evaluate the efficacy of non-pegylated liposomal doxorubicin (Myocet®) and cyclophosphamide in elderly women as HER2 negative first-line MBC treatment. Methods. 84 elderly women >70 years of age (median age 78 years) with MBC HER2 negative were enrolled. Performance Status in 58 patients was ECOG-0 and in 26 patients was ECOG-1. Results. The drug was well tolerated, with overall response rates were >40%, median overall survival was 16.2 months (95%CI:14.6- 18.8…

Ca 15-3 Cyclophosphamide Elderly woman Metastatic breast cancer Non-pegylated liposomal doxorubicin Quality of lifeTreatment OutcomeDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsHumansBreast NeoplasmsFemaleCyclophosphamideCardiotoxicityAgedPolyethylene GlycolsRetrospective StudiesLa Clinica terapeutica
researchProduct

Reactions and textures in grossular–wollastonite–scapolite calc–silicate granulites from Maligawila, Sri Lanka: evidence for high-temperature isobari…

2001

Grossular–wollastonite–scapolite calc–silicate granulites from Maligawila in the Buttala klippe, which form part of the overthrusted rocks of the Highland Complex of Sri Lanka, preserve a number of spectacular coronas and replacement textures that could be effectively used to infer their P–T–fluid history. These textures include coronas of garnet, garnet–quartz, and garnet–quartz–calcite at the grain boundaries of wollastonite, scapolite, and calcite as well as calcite–plagioclase and calcite– quartz symplectites or finer grains after scapolite and wollastonite respectively. Other textures include a double rind of coronal scapolite and coronal garnet between matrix garnet and calcite. The r…

CalciteGrossularMetamorphic rockGeochemistryScapoliteMineralogyMetamorphismGeologyengineering.materialGranuliteWollastonitechemistry.chemical_compoundchemistryGeochemistry and Petrologyvisual_artengineeringvisual_art.visual_art_mediumMetasomatismGeologyLithos
researchProduct

Predictive factors for lymph node involvement in sporadic medullary thyroid microcarcinoma: A systematic review

2022

Objective: The aim of the study was to determine the impact of laboratory and imaging tests in predicting central and lateral neck lymph node/LN involvement and in decision making for surgical extent. Materials and Methods: A PubMed, Web of Science and Scopus search was performed according to PRISMA criteria. The relationship between nodule size, diagnostic biomarkers and imaging with LN involvement were evaluated. Results: The available data analysis did not yield clear indications of the relationship between each of these topics and the presence, number, and location of LN involved. There was no conclusive data for the selective indication of central neck dissection in the preoperative di…

CalcitoninLymphatic MetastasisThyroidectomyHumansNeck DissectionMedullary thyroid microcarcinomaLymph NodesThyroid NeoplasmsCervical lymph node dissectionRetrospective Studies
researchProduct

Origin of clay minerals in soils on pyroclastic deposits in the island of Lipari (Italy)

2005

The island of Lipari (Italy) is characterized by calc-alkaline to potassic volcanism and a Mediterranean-type climate. The mineralogical and chemical features of two different soil profiles with ages of 92,000 and 10,000–40,000 y, respectively, have been investigated. There were no Andisols, but Vitric and Vertic Cambisols have developed at both sites. Although the morphology of the soils was similar, remarkable differences in the clay mineralogy between the two sites were observed. The site with the Vitric Cambisol was associated with the weathering sequence: glass → halloysite → kaolinite or interstratified kaolinite-2:1 clay minerals. Both sites had smectite in the clay fraction and, to …

CambisolGeochemistrySoil ScienceMineralogyWeatheringAndisols geochemistry montmorillonite glasses kaolinite sheet silicates Italy Cambisols clay mineralogy Europe silicates soils halloysite Lipari Islands clay minerals igneous rocks Lipari Island smectite metasomatism weathering Sicily Italy volcanic rocks Southern Europeengineering.materialHalloysitechemistry.chemical_compoundMontmorillonitechemistrySettore AGR/14 - PedologiaGeochemistry and PetrologySoil waterEarth and Planetary Sciences (miscellaneous)engineeringSoil horizonKaoliniteClay mineralsGeologyWater Science and Technologyclays and clay minerals
researchProduct

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological c…

2022

Abstract Background The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testing in Spain. Patients and methods The Thoracic Tumours Registry (TTR) is an observational, prospective, registry-based study that included patients diagnosed with lung cancer and other thoracic tumours, from September 2016 to 2020. This TTR study was sponsored by the Spanish Lung Cancer Group (GECP) Foundation, an independent, scientific, multidisciplinary oncology society that coordinates…

Cancer Research:Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [DISEASES]Lung NeoplasmsTesting:Biological Factors::Biomarkers [CHEMICALS AND DRUGS]:factores biológicos::biomarcadores [COMPUESTOS QUÍMICOS Y DROGAS]Targeted therapiesPulmons - Càncer:neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares [ENFERMEDADES]Carcinoma Non-Small-Cell LungProto-Oncogene ProteinsGeneticsBiomarkers TumorHumansProspective StudiesCàncerDemographyReceptor Protein-Tyrosine KinasesProtein-Tyrosine KinasesErbB ReceptorsOncologySpainPulmonsMarcadors bioquímicsBiomarkersMetastatic lung cancer
researchProduct

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

1999

We have previously reported that immune anti-tumor effector cells, both cytotoxic T lymphocytes (CTLs) and IL-2-activated natural killer (A-NK) cells, are effective at eliminating human head-and-neck cancer (HNC) targets in vitro and in vivo in xenograft models. In this study, these 2 types of human effector cell were compared for the ability to prevent the development of lymph node metastases in a metastasis model of human squamous-cell carcinoma of the head and neck (SCCHN) established in nude mice. A tumor cell line, OSC-19, was injected into the floor of the mouth in nude mice, and the tumor grew progressively and metastasized to cervical lymph nodes by day 21. As effector cells, a huma…

Cancer ResearchAdoptive cell transferPathologymedicine.medical_specialtyLymphokine-activated killer cellbusiness.industrymedicine.medical_treatmentImmunotherapymedicine.diseaseNatural killer cellMetastasismedicine.anatomical_structureOncologyCervical lymph nodesmedicineCytotoxic T cellbusinessLymph nodeInternational Journal of Cancer
researchProduct

Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It

2021

Drug resistance, which is often of a multiple type, can be defined as the ability of cancer cells to obtain resistance to both conventional and novel chemotherapy agents. It remains a major problem to solve in cancer therapy. The mechanisms of resistance are multifactorial, and in our cellular models of acute myeloid leukemia, hepatocellular carcinoma, and triple-negative breast cancer, it involves the NF-κB pathway. In our opinion, multitarget molecules can be considered as privileged compounds capable of attacking and reversing the resistant phenotype. In the phenomena of both innate and acquired drug resistance that we have been studying since 1998 to today and up to 2016 under the guida…

Cancer ResearchAntineoplastic AgentsApoptosisPhosphatidylethanolamine Binding ProteinDrug resistanceMetastasisBreast cancerdrug resistance P-glycoprotein IAP NF-κBNeoplasmsHumansMedicineATP Binding Cassette Transporter Subfamily B Member 1Transcription factorYY1 Transcription FactorP-glycoproteinbiologybusiness.industryKinaseNF-kappa BMyeloid leukemiamedicine.diseaseDrug Resistance NeoplasmCancer cellSettore BIO/14 - Farmacologiabiology.proteinCancer researchbusinessCritical Reviews™ in Oncogenesis
researchProduct